Multimodal AI Diagnostic Engine With Audit-Gated Federated Learning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional diagnostic methods for neurodegenerative disorders rely on single data modalities, leading to delayed intervention and reduced predictive accuracy, lack adaptive oversight, and fail to integrate multiple data sources securely while maintaining patient privacy and regulatory compliance.
Innovation Solution
A computer-implemented diagnostic engine that integrates neuroimaging, biochemical, and genomic data within a federated-learning framework, ensuring patient confidentiality and regulatory compliance through a Compliance Audit Layer that allows continual learning with transparent model updates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional single-modality diagnostic methods are used, then system complexity is low, but predictive accuracy is reduced and intervention is delayed
Solution Approach 1:
The patent combines multiple diagnostic modalities (neuroimaging, proteomics, genomics, digital behavioral data) into a unified federated learning framework. This merging of data sources and analytical methods enables comprehensive disease prediction while maintaining system manageability through modular architecture and standardized data processing pipelines.
2Measurement precision
If multimodal datasets are integrated, then predictive accuracy improves, but patient privacy and regulatory traceability are compromised
Solution Approach 1:
The system segments the centralized data processing into distributed local nodes that participate in federated learning. Each node processes data locally and contributes only model updates to the global model, preventing direct access to raw patient data while still enabling multimodal integration. This segmentation preserves patient privacy while achieving high predictive accuracy.
Solution Approach 2:
The patent introduces a compliance audit layer as an intermediary between data processing and regulatory requirements. This layer implements cryptographic verification, audit logging, and governance protocols that mediate between the need for data integration and the requirement for privacy protection, enabling traceable yet confidential multimodal analysis.
3Adaptability or versatility
If static AI diagnostic systems are used, then regulatory compliance is easier, but adaptive learning and model evolution are prevented
Solution Approach 1:
The system transitions from static to dynamic AI through federated continual learning, where models adapt to new data and emerging biomarkers over time. The architecture enables dynamic model evolution while maintaining regulatory compliance through version control, audit logging, and governance protocols that track and verify each adaptation step.
Solution Approach 2:
The compliance audit layer implements feedback mechanisms that monitor model performance, detect drift, and trigger retraining cycles. This feedback loop ensures continuous improvement while maintaining regulatory oversight, allowing the system to adapt learningly while demonstrating controlled evolution to regulators through verifiable audit trails.
Data Source
AI summary
A computer-implemented diagnostic engine integrates neuroimaging, biochemical, genomic, and behavioral data to detect and monitor neurodegenerative disorders. The system fuses multimodal inputs within a federated, explainable AI framework and records all training, drift, and ledger-vote events in a cryptographically verified ledger. Any model update exceeding a 0.7 percent drift threshold is submitted for ledger approval before deployment, enabling audit-gated continual learning aligned with FDA § 510(k) standards. A validated prototype achieves an AUC of 0.93 for early Alzheimer's detection and ensures compliance, privacy, and global interoperability.